Use of human epididymis protein 4 (he4) for assessing responsiveness of muc 16-positive cancer treatment
US-2023064677-A1 · Mar 2, 2023 · US
This page is not indexed by search engines while we improve data quality.
Lackner Mark patents
Lackner Mark is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lackner Mark |
| Total patents | 8 |
| First publication | Sep 22, 2016 |
| Latest publication | Mar 2, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of human epididymis protein 4 (HE4) for assessing responsiveness of MUC 16-positive cancer treatment
US-11440969-B2 · Sep 13, 2022 · US
Genetic variations associated with drug resistance
US-11021711-B2 · Jun 1, 2021 · US
Use of human epididymis protein 4 (he4) for assessing responsiveness of muc 16-positive cancer treatment
US-2019233538-A1 · Aug 1, 2019 · US
Genetic variations associated with drug resistance
US-2018298387-A1 · Oct 18, 2018 · US
Genetic variations associated with drug resistance
US-9879267-B2 · Jan 30, 2018 · US
Compositions and methods for prostate cancer analysis
US-9632091-B2 · Apr 25, 2017 · US
Compositions and methods for prostate cancer analysis
US-2016274116-A1 · Sep 22, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Genentech Inc | 8 |
| Lackner Mark | 1 |
| Amler Lukas C | 1 |
| Cavet Guy | 1 |
| O'Brien Carol | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 8 |
| G01N33/57557 | 3 |
| G01N33/57545 | 3 |
| G01N33/5758 | 3 |
| C07K16/2896 | 3 |